CD4 and pneumonia: In the colistin-resistant pneumonia model, treatment with a single dose of memory B or CD4+ T cells also reduced the bacterial load in the lungs compared with the tigecycline and sulbactam groups and was better than the tigecycline group in terms of blood clearance.